TY - JOUR
KW - Adult
KW - Humans
KW - *Renal Dialysis
KW - Retrospective Studies
KW - Cohort Studies
KW - Electronic Health Records
KW - *Renal Insufficiency, Chronic/diagnosis
KW - Hospitals
KW - United Kingdom
KW - chronic kidney disease
KW - Hemodialysis
KW - Hyperkalemia
KW - pneumonia
KW - Sepsis
AU - D. Little
AU - M. Arnold
AU - K. Hedman
AU - P. Sun
AU - S. Haque
AU - G. James
AD - Late Cardiovascular, Renal, Metabolism, BioPharmaceuticals R&D, AstraZeneca, Gaithersburg, MD, 20876, USA. Dustin.little@astrazeneca.com.
Real World Data Science, BioPharmaceuticals Medical, AstraZeneca, Cambridge, UK.
Biometrics CVRM, BioPharmaceuticals R&D, AstraZeneca, Gothenburg, Sweden.
Real World Data Science, Oncology Business Unit, AstraZeneca, Cambridge, UK.
Global Patient Safety BioPharma, BioPharmaceuticals Medical, AstraZeneca, Gaithersburg, MD, USA.
Cardiovascular, Renal, Metabolism Epidemiology, BioPharmaceuticals Medical, AstraZeneca, Cambridge, UK.
Present Address: Integrated Evidence Generation & Business Innovation, Bayer PLC, Reading, UK.
AN - 37020294
BT - BMC Nephrol
C2 - PMC10077632
DO - 10.1186/s12882-023-03119-z
DP - NLM
ET - 2023/04/06
LA - eng
M1 - 1
N1 - 1471-2369
Little, Dustin J
Arnold, Matthew
Hedman, Katarina
Sun, Ping
Haque, Syed Asif
James, Glen
Journal Article
Research Support, Non-U.S. Gov't
England
BMC Nephrol. 2023 Apr 5;24(1):91. doi: 10.1186/s12882-023-03119-z.
PY - 2023
SN - 1471-2369
EP - 91
T2 - BMC Nephrol
TI - Rates of adverse clinical events in patients with chronic kidney disease: analysis of electronic health records from the UK clinical practice research datalink linked to hospital data
VL - 24
ER -